XTLB
XTL Biopharmaceuticals
XTLB
XTLB
3 hedge funds and large institutions have $86K invested in XTL Biopharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
Holders
3
Holders Change
-1
Holders Change %
-25%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$25K |
Top Sellers
| 1 |
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$0 |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$2K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Invesco
Atlanta,
Georgia
| $59K | 25,961 | – | – |
|
|
2
Morgan Stanley
New York
| $25K | 10,761 | +1,601 | +17% |
|
|
3
UBS Group
Zurich,
Switzerland
| $2K | 703 | -2,337 | -77% |
|
|
4
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | – | -11,551 | Closed |
|